Vinta Laboratories Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 13.71 Cr
as on 12-12-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 61.88 Cr
as on 12-12-2024
- Satisfied Charges ₹ 22.92 Cr
as on 12-12-2024
- Revenue 180.35%
(FY 2021)
- Profit 84.33%
(FY 2021)
- Ebitda -6.23%
(FY 2021)
- Net Worth 69.08%
(FY 2021)
- Total Assets -15.72%
(FY 2021)
About Vinta Laboratories
The Corporate was formerly known as Swaasa Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 13.71 Cr.
The company currently has active open charges totaling ₹61.88 Cr. The company has closed loans amounting to ₹22.92 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vinta Laboratories Private Limited India is Shilpi Agarwal as COMPANY SECRETARY. Prakash Vinta, Sreenivasulu Mallu, Dayakar Mallu, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232AP2012PTC081966
- Company No.
081966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vinta Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilpi Agarwal  | Company Secretary | 02-Jan-2024 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sashank Vinta | Additional Director | 22-Feb-2022 | Current |
| Sreenivasulu Mallu | Director | 04-Sep-2019 | Current |
| Prakash Vinta | Additional Director | 22-Feb-2022 | Current |
Dayakar Mallu  | Director | 04-Sep-2019 | Current |
| Neelima Mallu | Director | 04-Sep-2019 | Current |
Financial Performance of Vinta Laboratories.
Vinta Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 180.35% increase. The company also saw a substantial improvement in profitability, with a 84.33% increase in profit. The company's net worth Soared by an impressive increase of 69.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vinta Laboratories?
In 2021, Vinta Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Viplus Pharmaceuticals Private LimitedActive 4 years 1 month
Prakash Vinta and Sashank Vinta are mutual person
- Therazymes Pharmaceuticals Private LimitedActive 6 years 2 months
Sreenivasulu Mallu and Dayakar Mallu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Sep 2023 | ₹4.00 Cr | Open |
Others Creation Date: 16 Sep 2023 | ₹4.00 Cr | Open |
Others Creation Date: 14 Sep 2023 | ₹5.62 M | Open |
How Many Employees Work at Vinta Laboratories?
Vinta Laboratories has a workforce of 159 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vinta Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vinta Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
